Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud H J Verstegen

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Obstetrics and Gynaecology Research|January 22, 2019
Drugs in lactationRuud H J Verstegen, Shinya Ito
Clinical Pharmacology and Therapeutics|October 5, 2019
The Future of Precision MedicineRuud H J Verstegen, Shinya Ito
Rheumatology (Oxford, England)|March 4, 2025
Comment on: Acute respiratory distress syndrome after emapalumab treatment in a child with severe Still's disease and lung involvement: a case reportVivian E Saper, Ruud H J Verstegen
Journal of Clinical Immunology|July 9, 2020
Inborn Errors of Adaptive Immunity in Down SyndromeRuud H J Verstegen, Maaike A A Kusters
The Journal of Allergy and Clinical Immunology. in Practice|May 26, 2023
Flaws and Limitations of Classification Criteria for Drug Reaction With Eosinophilia and Systemic SymptomsCathryn Sibbald, Neil H Shear, Ruud H J Verstegen
British Journal of Clinical Pharmacology|August 30, 2020
Infant drug exposure via breast milkRuud H J Verstegen, Philip O Anderson, Shinya Ito
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Pharmacogenetic Testing of Children and Adolescents with Mental Health Conditions: Real-World ExperiencesApril Kennedy, Sierra Scodellaro, Ruud H J Verstegen, et al.
Clinical and Experimental Dermatology|January 17, 2025
Outcomes of ciclosporin treatment in paediatric patients with drug reaction with eosinophilia and systemic symptoms (DRESS): a retrospective cohort analysisHaleh Zabihi, Khalad Maliyar, Cathryn Sibbald, et al.
Annals of the Rheumatic Diseases|October 3, 2025
Correspondence on 'Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15'Vivian E Saper, Ruud H J Verstegen, Gail H Deutsch
Frontiers in Medicine|February 27, 2023
First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroidsRuud H J Verstegen, Elizabeth J Phillips, David N Juurlink
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Obstetrics and Gynaecology Research|January 22, 2019
Drugs in lactationRuud H J Verstegen, Shinya Ito
Clinical Pharmacology and Therapeutics|October 5, 2019
The Future of Precision MedicineRuud H J Verstegen, Shinya Ito
Rheumatology (Oxford, England)|March 4, 2025
Comment on: Acute respiratory distress syndrome after emapalumab treatment in a child with severe Still's disease and lung involvement: a case reportVivian E Saper, Ruud H J Verstegen
Journal of Clinical Immunology|July 9, 2020
Inborn Errors of Adaptive Immunity in Down SyndromeRuud H J Verstegen, Maaike A A Kusters
The Journal of Allergy and Clinical Immunology. in Practice|May 26, 2023
Flaws and Limitations of Classification Criteria for Drug Reaction With Eosinophilia and Systemic SymptomsCathryn Sibbald, Neil H Shear, Ruud H J Verstegen
British Journal of Clinical Pharmacology|August 30, 2020
Infant drug exposure via breast milkRuud H J Verstegen, Philip O Anderson, Shinya Ito
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Pharmacogenetic Testing of Children and Adolescents with Mental Health Conditions: Real-World ExperiencesApril Kennedy, Sierra Scodellaro, Ruud H J Verstegen, et al.
Clinical and Experimental Dermatology|January 17, 2025
Outcomes of ciclosporin treatment in paediatric patients with drug reaction with eosinophilia and systemic symptoms (DRESS): a retrospective cohort analysisHaleh Zabihi, Khalad Maliyar, Cathryn Sibbald, et al.
Annals of the Rheumatic Diseases|October 3, 2025
Correspondence on 'Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15'Vivian E Saper, Ruud H J Verstegen, Gail H Deutsch
Frontiers in Medicine|February 27, 2023
First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroidsRuud H J Verstegen, Elizabeth J Phillips, David N Juurlink
Pageof 5